TXNRD2 and Miyoshi myopathy: Similarly, the reestablishment of regular TXNRD2 quantity in MM cells after administration of proteasome inhibitors decreases ER, oxidative stress, and cell death, and ectopic production of TXNRD2 in MM cell xenografts in immunocompromised animals reduces the efficacy of BTZ [41].